2-Aminosulfonyl-N,N-Dimethylnicotinamide

We are 2-Aminosulfonyl-N,N-Dimethylnicotinamide CAS:112006-75-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 112006-75-4
Product Name: 2-Aminosulfonyl-N,N-Dimethylnicotinamide
Other Name:
2-Aminosulfonyl-N,N-Dimethylnicotinamide
N,N-Dimethyl-2-sulfamoylnicotinamide
N,N-dimethyl-2-sulfamoylpyridine-3-carboxamide
2-(Aminosulfonyl)-N,N-dimethyl-3-pyridinecarboxamidetinamide
N,N-Dimethylnicotinamide-2-sulfonamide
 
Density: 1.4±0.1 g/cm3
Boiling Point: 488.9±55.0 °C at 760 mmHg
Molecular Formula: C8H11N3O3S
Molecular Weight: 229.256
Flash Point: 249.5±31.5 °C
Exact Mass: 229.052109
PSA: 101.74000
LogP: -2.21
Vapour Pressure: 0.0±1.2 mmHg at 25°C
Index of Refraction: 1.571
 
Specification
Appearance: Off-white solid powder
Assay: ≥98.0%
Water: ≤0.5%
 
Application
Intermediates of Nicosulfuron CAS: 111991-09-4.
An important pesticide intermediate for the synthesis of the herbicide nicosulfuron.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

2-Aminosulfonyl-N,N-Dimethylnicotinamide


Related News: Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.toluene-4-sulfonic acid CAS:104-15-4 Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.153977-22-1 Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country.2- (3- (3 – ((7-cloroquinolin-2-il) (tiofen-2-il) metil) fenil) -3-oxopropil) benzoato de metilo CAS:133791-17-0 Process: The importance of safety is obvious. The research and development of specialty drug substances (especially high-barrier generic drug substance drugs) usually need to avoid the original process patents, and some chemicals are developed because of the complex structure or the harsh synthetic conditions The synthetic route is more difficult, so the importance of process design capabilities of API companies is becoming more important.This is of vital important and underlies one of the most solid principles and regulations of modern pharmacy.

Related Products
Product Name
3-bromo-5-methylpyridine View Details
4-Fluoro-2-iodoaniline View Details
D-Alanine View Details
Trimethoxy[2-(7-oxabicyclo[4.1.0]hept-3-yl)ethyl]silane manufacturer N-(3-chloro-4-fluorophenyl)-7-(3-morpholin-4-ylpropoxy)-6-nitroquinazolin-4-amine manufacturer 2-Bromo-4-Hydroxypyridine manufacturer 3-[di(propan-2-yl)amino]propan-1-ol manufacturer Z-Glu(OtBu)-OH manufacturer